Feb 3, 2026
What are the current FDA‑approved and controversial treatments for Alzheimer’s and their evidence bases?
Two classes of treatments exist today: longstanding symptomatic drugs that modestly delay decline (cholinesterase inhibitors and memantine) and a new wave of anti‑amyloid immunotherapies that reduce b...